Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
compound acorus tatarinowii + bismuth subnitrate
- Development stage
- Unknown
- Lead developer
- Sinopharm Xingsha
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Compound Acorus Tatarinowii and Bismuth Subnitrate Tablets is a gastrointestinal medication developed and manufactured by Sinopharm Xingsha Pharmaceuticals. It is a compound formulation that combines the mucosal protective properties of bismuth subnitrate with the traditional Chinese medicinal benefits of *Acorus tatarinowii* (Shi Chang Pu). Bismuth subnitrate works by forming a protective coating over gastric and duodenal ulcers, shielding them from gastric acid and pepsin, while also exhibiting mild antacid and antibacterial properties against *Helicobacter pylori*. The formulation typically includes other antacids such as sodium bicarbonate and magnesium carbonate to neutralize excess stomach acid, and *Acorus tatarinowii* to promote digestion and alleviate symptoms like bloating and abdominal pain. It is indicated for the treatment of gastric and duodenal ulcers, chronic gastritis, and gastric hyperacidity.
- Brand names
- Xingsha
- Other names
- 复方石菖蒲碱式硝酸铋片Compound Acorus Tatarinowii and Bismuth Subnitrate TabletsCompound Bismuth Subnitrate Tablets
Beyond the preview
Go deeper on compound acorus tatarinowii + bismuth subnitrate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on compound acorus tatarinowii + bismuth subnitrate.